Editorial
Compensation for research injuries: Thoughts from a human research ethics committee chair
Peter Cleaton-Jones
Abstract
In the first clinical trial compensation court case in South Africa (Venter vs Roche Products (Pty) Limited and Others (case no. 12285/08), Association of the British Pharmaceutical Industry guidelines compensation limited a participant to appropriate medical treatment, which is common in many countries. Change in policy is likely to take years, but what could be done rapidly for potential clinical trial participants is to make the limitation more obvious by placing this in a separate page instead of in a small section near the end of multipage information and consent document.
Author's affiliations
Peter Cleaton-Jones, Chair, Human Research Ethics Committee (Medical), University of the Witwatersrand, Johannesburg, South Africa
Keywords
Research-related injury; Compensation
Article History
Date submitted: 2014-09-20
Date published: 2014-09-20
Article Views
Abstract views: 2134
Full text views: 3499
Comments on this article
*Read our policy for posting comments
here
Comments on this article
*Read our policy for posting comments here